From pills to new uses, here's what Eli Lilly's top scientist sees as the future of weight loss drugs / Eli Lilly aims to invest in 'big problems hiding in plain sight' using obesity windfall / Eli Lilly wants to use its weight loss drug windfall to fight Alzheimer's and hearing loss / Eli Lilly to release late-stage data on next-generation weight loss drug retatrutide in 2025, earlier than expected / Eli Lilly beats on earnings even as weight loss, diabetes drug sales fall short / Diabetes and obesity drugs fuel Eli Lilly profit in the final quarter of 2024 / Stocks making the biggest moves premarket: Ford, Eli Lilly, Honeywell, Arm Holdings and more / Eli Lilly has its mojo back ahead of a pivotal year for the obesity drug giant / Eli Lilly expects to beat profit forecasts on obesity drug demand / Eli Lilly must put to rest doubts about whether Zepbound's growth can live up to the hype